Fresenius Kabi USA recalls Fresenius Kabi — Ketorolac Tromethamine Injection, USP, 30 mg/mL
- Recall date
- January 8, 2021
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Fresenius Kabi USA, Fresenius Kabi
Why it was recalled
Presence of particulate matter — Impurity
What was recalled
Ketorolac Tromethamine Injection, USP, 30 mg/mL
Read the official recall notice →
Get recall alerts
Free email alert whenever Fresenius Kabi USA has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Fresenius Kabi USA, Fresenius Kabi